Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Reinmuth

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Pneumologie (Stuttgart, Germany)|August 11, 2015
[ROS1-Translocations in Non-Small Cell Lung Cancer]A Warth, W Weichert, M Reck, et al.
Pneumologie (Stuttgart, Germany)|March 16, 2010
[New strategies for NSCLC: is inhibition of tumour vasculature useful]N Reinmuth, M Steins, M Kreuter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
PD-L1 copy number gain in nonsmall-cell lung cancer defines a new subset of patients for anti PD-L1 therapyT Goldmann, C Kugler, N Reinmuth, et al.
Pneumologie (Stuttgart, Germany)|September 10, 2014
[A reduced TKI dosage is not associated with loss of activity in EGFR mutated NSCLC patients]N Reinmuth, D Heigener, T Goldmann, et al.
The European Respiratory Journal|October 5, 2010
Current data on predictive markers for anti-angiogenic therapy in thoracic tumoursN Reinmuth, M Thomas, M Meister, et al.
Pneumologie (Stuttgart, Germany)|September 8, 2016
[Therapy of Metastatic Non-small Cell Lung Cancer]N Reinmuth, A Gröschel, C Schumann, et al.
Pneumologie (Stuttgart, Germany)|December 23, 2017
[Updated Recommendation for Treatment of Metastatic Non-Small Cell Lung Cancer]N Reinmuth, A Gröschel, C Schumann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2014
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upM Reck, S Popat, N Reinmuth, et al.
Oncology (Williston Park, N.Y.)|August 11, 2001
Role of angiogenesis inhibitors in cancer treatmentL M Ellis, W Liu, F Fan, et al.
The European Respiratory Journal|January 12, 2001
Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancerN Reinmuth, B Brandt, W P Kunze, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Pneumologie (Stuttgart, Germany)|August 11, 2015
[ROS1-Translocations in Non-Small Cell Lung Cancer]A Warth, W Weichert, M Reck, et al.
Pneumologie (Stuttgart, Germany)|March 16, 2010
[New strategies for NSCLC: is inhibition of tumour vasculature useful]N Reinmuth, M Steins, M Kreuter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
PD-L1 copy number gain in nonsmall-cell lung cancer defines a new subset of patients for anti PD-L1 therapyT Goldmann, C Kugler, N Reinmuth, et al.
Pneumologie (Stuttgart, Germany)|September 10, 2014
[A reduced TKI dosage is not associated with loss of activity in EGFR mutated NSCLC patients]N Reinmuth, D Heigener, T Goldmann, et al.
The European Respiratory Journal|October 5, 2010
Current data on predictive markers for anti-angiogenic therapy in thoracic tumoursN Reinmuth, M Thomas, M Meister, et al.
Pneumologie (Stuttgart, Germany)|September 8, 2016
[Therapy of Metastatic Non-small Cell Lung Cancer]N Reinmuth, A Gröschel, C Schumann, et al.
Pneumologie (Stuttgart, Germany)|December 23, 2017
[Updated Recommendation for Treatment of Metastatic Non-Small Cell Lung Cancer]N Reinmuth, A Gröschel, C Schumann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2014
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upM Reck, S Popat, N Reinmuth, et al.
Oncology (Williston Park, N.Y.)|August 11, 2001
Role of angiogenesis inhibitors in cancer treatmentL M Ellis, W Liu, F Fan, et al.
The European Respiratory Journal|January 12, 2001
Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancerN Reinmuth, B Brandt, W P Kunze, et al.
Pageof 5